DHCNL · Insider Trading
Diversified Healthcare Trust 6.25% Senior Notes Due 2046
Every open-market purchase and sale reported by DHCNL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Matthew C. Brown | CFO and Treasurer | F | −13,895 | −$112.97K |
| 2026-09-21 | Adam D. Portnoy | Director | F | −19,315 | −$157.03K |
| 2026-09-21 | Christopher J. Bilotto | President and CEO | F | −25,118 | −$204.21K |
| 2026-09-14 | Matthew C. Brown | CFO and Treasurer | A | +53,050 | — |
| 2026-09-14 | Christopher J. Bilotto | President and CEO | A | +59,681 | — |
| 2026-09-14 | Adam D. Portnoy | Director | A | +59,681 | — |
| 2026-06-12 | Lisa Harris Jones | Director | A | +12,401 | — |
| 2026-06-12 | Alan L. Felder | Director | A | +12,401 | — |
| 2026-06-12 | Phyllis M. Hollis | Director | A | +12,401 | — |
| 2026-06-12 | Dawn K. Neher | Director | A | +12,401 | — |
| 2026-06-12 | Jeffrey P. Somers | Director | A | +12,401 | — |
| 2026-06-12 | Christopher J. Bilotto | President and CEO | A | +12,401 | — |
| 2026-06-12 | Adam D. Portnoy | Director | A | +12,401 | — |
| 2025-12-16 | Christopher J. Bilotto | President and CEO | Buy | +20,000 | +$97.72K |
| 2025-09-18 | Adam D. Portnoy | Director | F | −15,226 | −$66.54K |
| 2025-09-18 | Matthew C. Brown | CFO and Treasurer | F | −9,711 | −$42.44K |
| 2025-09-18 | Christopher J. Bilotto | President and CEO | F | −17,091 | −$74.69K |
| 2025-09-11 | Matthew C. Brown | CFO and Treasurer | A | +37,383 | — |
| 2025-09-11 | Christopher J. Bilotto | President and CEO | A | +81,775 | — |
| 2025-09-11 | Adam D. Portnoy | Director | A | +81,775 | — |
| 2025-06-02 | Jeffrey P. Somers | Director | A | +29,141 | — |
| 2025-06-02 | Alan L. Felder | Director | A | +29,141 | — |
| 2025-06-02 | Phyllis M. Hollis | Director | A | +29,141 | — |
| 2025-06-02 | Christopher J. Bilotto | President and CEO | A | +29,141 | — |
| 2025-06-02 | Adam D. Portnoy | Director | A | +29,141 | — |
| 2025-06-02 | Dawn K. Neher | Director | A | +29,141 | — |
| 2025-06-02 | Lisa Harris Jones | Director | A | +29,141 | — |
| 2025-03-20 | Alan L. Felder | Director | A | +33,582 | — |
| 2024-11-14 | Matthew C. Brown | CFO and Treasurer | Buy | +2,000 | +$5.10K |
| 2024-09-19 | Christopher J. Bilotto | President and CEO | F | −10,537 | −$38.78K |
| 2024-09-19 | Adam D. Portnoy | Director | F | −6,570 | −$24.18K |
| 2024-09-19 | Matthew C. Brown | CFO and Treasurer | F | −6,187 | −$22.77K |
| 2024-09-13 | Christopher J. Bilotto | President and CEO | A | +74,626 | — |
| 2024-09-13 | Matthew C. Brown | CFO and Treasurer | A | +40,298 | — |
| 2024-09-13 | Adam D. Portnoy | Director | A | +74,626 | — |
| 2024-06-04 | Lisa Harris Jones | Director | A | +37,037 | — |
| 2024-06-04 | Phyllis M. Hollis | Director | A | +37,037 | — |
| 2024-06-04 | Dawn K. Neher | Director | A | +37,037 | — |
| 2024-06-04 | Jeffrey P. Somers | Director | A | +37,037 | — |
| 2024-06-04 | Christopher J. Bilotto | President and CEO | A | +37,037 | — |
| 2024-06-04 | Adam D. Portnoy | Director | A | +37,037 | — |
| 2024-06-04 | John L. Harrington | Director | MIXED | +37,037 | — |
| 2023-09-26 | Phyllis M. Hollis | Director | A | +20,000 | — |
| 2023-09-20 | Richard W. Siedel Jr. | CFO and Treasurer | F | −7,086 | −$16.51K |
| 2023-09-20 | Jennifer F. Francis | President and CEO | F | −15,839 | −$36.90K |
| 2023-09-15 | Jennifer F. Francis | President and CEO | A | +60,000 | — |
| 2023-06-14 | Adam D. Portnoy | Director | Buy | +6,003,515 | +$17.94M |
| 2023-06-09 | Adam D. Portnoy | Director | Buy | +5,995,200 | +$14.72M |
| 2023-06-06 | Daniel F. LePage | Director | A | +20,000 | — |
| 2023-06-06 | Jennifer F. Francis | President and CEO | A | +20,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Adam D. Portnoy | Director | 23,717,942 | $453.72M |
| Christopher J. Bilotto | President and CEO | 314,066 | $6.01M |
| Jeffrey P. Somers | Director | 177,079 | $3.39M |
| Lisa Harris Jones | Director | 170,287 | $3.26M |
| Matthew C. Brown | CFO and Treasurer | 153,109 | $2.93M |
| Phyllis M. Hollis | Director | 100,147 | $1.92M |
| Dawn K. Neher | Director | 78,579 | $1.50M |
| Alan L. Felder | Director | 75,124 | $1.44M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DHCNL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.